Key result
Cigarette smoking linked to progressively lower HDL-C, reaching ~/dL lower in heavy smokers.
Why the study?
Previous studies generally reported lower HDL-C concentrations among smokers, but the influence of different intensities of smoking on HDL-C levels required further evaluation.
Does cigarette smoking of varying intensities reduce serum high-density lipoprotein cholesterol (HDL-C) levels compared to non-smoking in healthy males aged 30–40 years?
Cross-Sectional (n=80)
No
Does cigarette smoking of varying intensities reduce serum high-density lipoprotein cholesterol (HDL-C) levels compared to non-smoking in healthy males aged 30–40 years?
Cigarette smoking is associated with a statistically significant, dose-dependent reduction in cardioprotective serum HDL-C levels among healthy young adult males.
Answers are grounded in this paper and cite their sources.
Smoking intensity linked to lower HDL-C; extends observational data but leaves open causality and cessation effects.
Introduction Cigarette smoking is a major modifiable risk factor for several chronic diseases, including atherosclerosis and cardiovascular disease. In addition to its direct toxic effects, cigarette smoking can adversely influence lipid metabolism and alter the concentration and function of circulating lipoproteins. High-density lipoprotein cholesterol (HDL-C) plays an important cardioprotective role through reverse cholesterol transport and other anti-atherogenic mechanisms. Previous studies have generally reported lower HDL-C concentrations among smokers; however, the influence of different intensities of smoking on HDL-C levels requires further evaluation. Objective The present study aimed to assess the effect of cigarette smoking on serum HDL-C levels in male smokers and to compare HDL-C concentrations among mild, moderate, and heavy smokers with those of healthy non-smokers. Methods This cross-sectional study was conducted over 12 months in the Department of Biochemistry in association with the Department of Respiratory Medicine at Santosh Medical College and Hospital, Ghaziabad, Uttar Pradesh. A total of 80 healthy male subjects aged 30–40 years were included. Twenty healthy non-smokers served as controls, while 60 smokers were categorized into mild, moderate, and heavy smoking groups, with 20 subjects in each group, according to smoking intensity expressed in pack-years. Subjects with alcohol consumption, previous smoking history, diabetes mellitus, hypertension, renal disease, chronic hepatic dysfunction, endocrine disorders, obesity, a family history of coronary heart disease, or the use of lipid-lowering drugs were excluded. Serum HDL-C was estimated following precipitation of LDL, VLDL, and chylomicrons, followed by enzymatic estimation of cholesterol in the supernatant. Results A progressive decline in serum HDL-C levels was observed with increasing smoking intensity. The mean ± SD HDL-C levels were 48.94 ± 3.92 mg/dL in controls, 38.31 ± 3.16 mg/dL in mild smokers, 32.10 ± 2.15 mg/dL in moderate smokers, and 30.71 ± 2.48 mg/dL in heavy smokers. The corresponding 95% confidence intervals were 47.11–50.78, 36.83–39.79, 31.09–33.11, and 29.55–31.87 mg/dL, respectively. HDL-C levels were significantly lower among smokers compared with controls, with a progressive reduction observed with increasing smoking intensity Discussion The findings demonstrate an adverse association between cigarette smoking and serum HDL-C concentration. The progressive decline in HDL-C with increasing smoking intensity supports a possible dose-related effect of smoking on lipid metabolism. Smoking-induced alterations in enzymes and proteins involved in HDL metabolism, including lecithin cholesterol acyltransferase and cholesteryl ester transfer protein, may contribute to reduced HDL-C levels and impaired cardioprotection. Conclusion Cigarette smoking was associated with significantly lower serum HDL-C levels, and greater smoking intensity was accompanied by a further reduction in HDL-C. These findings emphasize the importance of smoking prevention and cessation as part of strategies to reduce adverse cardiovascular risk.
No takes yet. Share an insight, caveat, or question.
Srivastva et al. (2026) conducted a cross-sectional in Cigarette smoking and dyslipidemia (n=80). Cigarette smoking (mild, moderate, and heavy intensity) vs. Healthy non-smokers was evaluated on Mean serum high-density lipoprotein cholesterol (HDL-C) level (mg/dL) in heavy smokers vs non-smoker controls (p=<0.001). Cigarette smoking was associated with progressively lower mean serum HDL-C levels from /dL in non-smokers to 38.31, 32.10, and /dL in mild, moderate, and heavy smokers.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: